Profile | GDS4284 / 215451_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 148.357 | 44 |
GSM687648 | Patient 402 control | 175.569 | 47 |
GSM687653 | Patient 403 control | 229.457 | 52 |
GSM687658 | Patient 404 control | 297.209 | 55 |
GSM687663 | Patient 411 control | 355.462 | 58 |
GSM687668 | Patient 422 control | 275.462 | 54 |
GSM687673 | Patient 424 control | 286.805 | 54 |
GSM687678 | Patient 425 control | 233.893 | 50 |
GSM687683 | Patient 427 control | 280.117 | 53 |
GSM687688 | Patient 428 control | 127.509 | 39 |
GSM687695 | Patient 441 control | 411.311 | 57 |
GSM687699 | Patient 443 control | 368.446 | 57 |
GSM687704 | Patient 444 control | 225.877 | 51 |
GSM687707 | Patient 448 control | 302.281 | 54 |
GSM687712 | Patient 449 control | 280.21 | 54 |
GSM687719 | Patient 450 control | 563.077 | 64 |
GSM687724 | Patient 451 control | 343.555 | 57 |
GSM687728 | Patient 452 control | 258.644 | 52 |
GSM687646 | Patient 401 treated 24h | 187.972 | 47 |
GSM687649 | Patient 402 treated 24h | 264.116 | 54 |
GSM687665 | Patient 411 treated 24h | 275.929 | 52 |
GSM687651 | Patient 402 treated 4 weeks | 328.708 | 56 |
GSM687667 | Patient 411 treated 4 weeks | 247.455 | 52 |
GSM687670 | Patient 422 treated 24h | 304.288 | 55 |
GSM687671 | Patient 422 treated 4 weeks | 242.523 | 52 |
GSM687654 | Patient 403 treated 24h | 249.502 | 54 |
GSM687675 | Patient 424 treated 24h | 345.07 | 57 |
GSM687685 | Patient 427 treated 24h | 284.722 | 54 |
GSM687656 | Patient 403 treated 4 weeks | 221.47 | 52 |
GSM687677 | Patient 424 treated 4 weeks | 275.386 | 54 |
GSM687687 | Patient 427 treated 4 weeks | 275.962 | 55 |
GSM687692 | Patient 428 treated 4h | 117.869 | 37 |
GSM687716 | Patient 449 treated 4h | 281.406 | 55 |
GSM687722 | Patient 450 treated 4h | 302.613 | 54 |
GSM687680 | Patient 425 treated 24h | 251.399 | 52 |
GSM687690 | Patient 428 treated 24h | 123.946 | 39 |
GSM687700 | Patient 443 treated 24h | 605.588 | 64 |
GSM687705 | Patient 444 treated 24h | 167.939 | 47 |
GSM687714 | Patient 449 treated 24h | 173.672 | 47 |
GSM687721 | Patient 450 treated 24h | 349.094 | 56 |
GSM687682 | Patient 425 treated 4 weeks | 200.039 | 49 |
GSM687694 | Patient 428 treated 4 weeks | 94.7199 | 35 |
GSM687702 | Patient 443 treated 4 weeks | 319.221 | 55 |
GSM687718 | Patient 449 treated 4 weeks | 192.898 | 48 |
GSM687723 | Patient 450 treated 4 weeks | 440.871 | 61 |
GSM687661 | Patient 404 treated 4h | 213.522 | 48 |
GSM687710 | Patient 448 treated 4h | 154.784 | 43 |
GSM687726 | Patient 451 treated 4h | 353.339 | 57 |
GSM687730 | Patient 452 treated 4h | 223.796 | 35 |
GSM687660 | Patient 404 treated 24h | 364.614 | 58 |
GSM687697 | Patient 441 treated 24h | 587.268 | 65 |
GSM687709 | Patient 448 treated 24h | 330.884 | 57 |
GSM687725 | Patient 451 treated 24h | 311.639 | 54 |
GSM687729 | Patient 452 treated 24h | 622.218 | 68 |
GSM687727 | Patient 451 treated 4 weeks | 260.967 | 51 |
GSM687731 | Patient 452 treated 4 weeks | 326.43 | 55 |